Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 27, 2015 12:41 AM ET

Life Sciences Tools and Services

Company Overview of Cirrus Pharmaceuticals, Inc.

Company Overview

Cirrus Pharmaceuticals, Inc. operates as a contract research and product development company. The company assists biotechnology and pharmaceutical companies in dosage form development projects. It provides various research and development services, such as physical and chemical characterization, formulation development, analytical, extractables and leachables, particle size analysis, peptides and proteins, nanotechnology, stability testing, device evaluation, process development, scale-up/tech transfer, regulatory submission, manufacturing oversight and batch release, packaging component evaluation and selection, and tox/batch manufacturing services for inhaled, nasal, oral, parenteral, topi...

511 Davis Drive

Suite 100

Durham, NC 27713

United States

Founded in 1997





Key Executives for Cirrus Pharmaceuticals, Inc.

Co-Founder, Chief Executive Officer and President
Director of Accounting and Finance
Executive Vice President
Director of Business Development
Associate Director of Quality Assurance
Compensation as of Fiscal Year 2015.

Cirrus Pharmaceuticals, Inc. Key Developments

Andrew Hamer Joins Cirrus Pharmaceuticals as VP R&D

Cirrus Pharmaceuticals announced that Andrew Hamer has joined as VP R&D. Andrew previously worked at GlaxoSmithKline as Senior Director R&D Operations in RTP.

Cirrus Pharmaceuticals to Invest in Flexible cGMP Suite in its Facility in RTP, North Carolina

Cirrus Pharmaceuticals announced that it will be investing in a flexible cGMP suite in its facility in RTP, North Carolina. With the addition of the cGMP suite, Cirrus will be able to extend its offerings in the US from contract development to manufacturing.

Similar Private Companies By Industry

Company Name Region
Cook General BioTechnology LLC United States
Diversigen, Inc. United States
Chiral Technologies, Inc. United States
Lumencor, Inc. United States
Buffalo Clinical Research Center, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cirrus Pharmaceuticals, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at